Most manufacturers are built for scale — large tooling investment, amortised over a high-volume run. That model works well for products that already exist at scale. Medical device innovation doesn‘t start there. It starts with a clinical validation build, a regulatory submission sample, a pilot batch that has to prove the design works before anyone commits to mass production — at quantities most commercial manufacturers won‘t quote seriously.

Low-volume production exists to close that gap. It isn‘t a smaller, cheaper version of mass production. It’s a manufacturing approach built specifically for this stage of the device lifecycle, where the part still has to meet the same standard the final device will be held to. We‘ve covered low-volume manufacturing for medical device industry before — this post goes one level deeper, into how the right process and the right documentation come together at each stage.

Every stage of a medical device program asks a different question of the part. The table below maps the process to the question it’s actually answering.

3D Printing — Design Validation. Prototypes are typically ready in 1 to 3 days, answering early questions about geometry, fitment, and complex feature accuracy across ABS–like, PC–like, Nylon, and Glass-Filled materials.

Vacuum Casting and RIM — Functional and Clinical Validation. Production–equivalent polyurethane grades, including biocompatible options, typically cover 10 to 100 parts per batch. RIM handles large device covers and housings — up to 2m in a single piece — without committing to hard tooling. This is the stage where surface finish, strength, and heat performance start to give a realistic read on how the final device will behave.

Soft Tooling — Regulatory Submission Samples and Pilot Batches. Exact production–intent biocompatible polymers — PC, ULTEM, TPU, PPSU — at 100 to 5,000 parts per program, with 2 to 6 weeks tooling lead time. Because the tool is built in aluminium or unhardened steel rather than hardened production steel, tooling investment runs roughly 50% lower than a production tool, while the parts themselves are dimensionally and materially the real thing. (We go deeper on how soft tooling delivers true engineering–grade parts in our soft tooling guide.)

Production Tooling — Series Production. 5 to 8 weeks tooling lead time, supporting runs into the hundreds of thousands of shots, once the program is validated and ready to scale. Same facility, same engineering team, same documentation trail carried forward from every stage before it — no vendor change and no re-qualification cycle at the point a program needs to scale.

Quality requirements don‘t relax because the batch is small. If anything, documentation matters more at low volume, because regulatory submissions depend on traceability that a mass-production batch can sometimes take for granted.

In practice, that means:

• Material certificates and Certificates of Analysis for every batch of biocompatible polymer used
• CMM and VMM dimensional inspection against the engineering drawing
• First Article Inspection on the first part of any new tool
• Sample Inspection Reports or Pre–Dispatch Inspection documentation before parts ship
• In–house DFM review and Moldflow simulation before tooling starts — not after

A design issue caught in DFM review costs nothing. The same issue caught after a soft tool is cut costs the tool, the timeline, and in a regulated program, potentially a re-submission. This is also where a manufacturing partner’s own quality system matters — our facilities and quality control are built around exactly this kind of traceability.

• A soft tool built to validate a surgical robot component’s design, in biocompatible PC with ultrasonic-welded assembly, can go on to supply production volumes for years before a production tool investment is even justified — the validation tool becoming the production solution, not a step that gets discarded once volumes grow.
• A new cannula design can move from concept to soft-tooled prototype in around three weeks when material, process, and DFM review are aligned from the start.
• Large device covers, difficult to justify in hard tooling at low quantities, run reliably through RIM at a steady monthly cadence with consistent finish quality.

None of these outcomes depended on treating a small batch as a lesser version of production. They depended on a manufacturing partner built to take that volume seriously in the first place — not adapted for it as an exception, but designed for it from the start.

• 25+ years of tooling and moulding experience
• 1,400+ tools developed across automotive, medical, electronics, and industrial sectors
• In-house DFM and Moldflow review before tooling starts — no external handoffs
• One partner, every stage — from 3D-printed validation builds through soft tooling to series production, with no vendor change and no re-qualification cycle
• Full documentation trail — material certificates, FAI, CMM/VMM inspection, and Sample Inspection Reports carried through every stage

Share your component requirements, target stage, and material specification. Our engineering team will recommend the right process, flag any DFM concerns before tooling starts, and provide a fixed-price quotation with a clear scope and timeline.

One partner from validation build to series production — no vendor change at any stage, and no quantity too small to take seriously.